Featured,Trends & Articles Washington City Votes in Favor of Decriminalizing Psychedelics By Dennis Mutua December 23, 2021 Earlier in the week, the city council of Port Townsend, Washington voted in favor of decriminalizing fungi and entheogenic plants across the city. This move makes the city to join an expanding list of cities and states across the ...
Psychedelic Stocks,Trends & Articles MindMed’s Clinical Study Using LSD to Treat Generalized Anxiety Disorder Put on Hold by FDA By Dennis Mutua December 22, 2021 The United States Food and Drug Administration (FDA) announced having put on hold an application by MindMed Inc. (NASDAQ: MNMD) to conduct a clinical study using psychedelic compound commonly referred to as LSD to treat patients s...
Psychedelic Stocks,Shroom News HAVN Life Sciences Enters Into an Agreement to Acquire Spore Life Sciences By Dennis Mutua December 21, 2021 Biotechnology company focusing on psychedelic therapies for treatment HAVN Life Sciences Inc. (CSE: HAVN) (OTCMKTS: HAVLF) announced having entered into a definitive agreement to acquire all outstanding securities of Spore Life Sc...
Featured,Spotlight Stock MYND Life Sciences Acquires Rights to Use Psychedelics to Treat Alzheimer’s Disease By Dennis Mutua December 20, 2021 Neuro-pharmaceutical drug development company focusing on advancing psychedelic medicine which mental illnesses MYND Life Sciences Inc. (CSE: MYND) (OTC: MYNDF) announced having successfully acquired the rights, interest and title...
Featured,Spotlight Stock First Ever Psychedelic Research and Therapy Center Launched in Texas By Dennis Mutua December 17, 2021 Researchers from Dell Medical School at the University of Texas Austin have launched a Center for Psychedelic Research and Therapy in Austin, Texas as part of the institution’s efforts to use psychedelics to treat various mental...
Featured,Spotlight Stock Cybin Granted Notice of Allowance for CYB004 in Treatment of Anxiety Disorder by USPTO By Dennis Mutua December 16, 2021 Biopharmaceutical company specializing on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols Cybin Inc. (NYSE: CYBN) announced been awarded a notice of allowance by the United States P...
Psychedelic Stocks,Trends & Articles Psyched Wellness Hires Del Mahabadi as its Marketing Consultant Ahead of AME-1 Product Launch By Dennis Mutua December 15, 2021 Health supplement company focusing on protection, restoration and regaining of a healthier body and mind through production and distribution of artisanal medical mushrooms Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) announced...
Shroom News,Spotlight Stock HAVN Life Sciences Exports Psilocybin Form Jamaica to U.S for Research Purposes By Dennis Mutua December 14, 2021 Biotechnology company creating psychedelic supply chain through research, extraction, formulation and delivery of psychedelics HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) announced having successfully exported naturally extra...